Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Colorectal Neoplasms

Free Subscription Articles published in Anticancer Res Retrieve available abstracts of 171 articles: HTML format

Single Articles

October 2026
1. SEKI Y, Shibutani M, Tanda H, Tsukida T, et al
   Vascular Proliferation Index Via a Single-Cell Analysis Is a Superior Prognostic Biomarker to Microvessel Density in Stage II/III Colorectal Cancer.
   Anticancer Res. 2026;46:5505-5515.
   PubMed     Abstract available
   
   
   
2. HARAGUCHI N, Yokoyama Y, Kubota Y, Kouda S, et al
   Hyperthermia Enhances the Effects of ICI by Increasing PD-L1 Expression Through Induction of CD8(+) Cell Infiltration.
   Anticancer Res. 2026;46:5399-5410.
   PubMed     Abstract available
   
   
   
3. ARIZONO M, Furukawa K, Tsunematsu M, Yamahata Y, et al
   Post-hepatectomy-related DIC Predicts Poor Survival After Resection for Colorectal Liver Metastases.
   Anticancer Res. 2026;46:5599-5608.
   PubMed     Abstract available
   
   
   
4. KAWAZOE T, Ando K, Ryujin K, Nambara S, et al
   Real-world Outcomes of Trifluridine/Tipiracil With or Without Bevacizumab in Metastatic Colorectal Cancer: A Retrospective Cohort Study.
   Anticancer Res. 2026;46:5553-5564.
   PubMed     Abstract available
   
   
   
5. CRISTAUDO AT, Morris DL
   Computational Modelling of CEA-CEAR Receptor Occupancy for Anti-CEA Therapy in Colorectal Liver Metastasis.
   Anticancer Res. 2026;46:5411-5419.
   PubMed     Abstract available
   
   
   
6. YAMANE T, Masuda T, Nagayama Y, Adachi Y, et al
   Multidisciplinary Treatment With Repeated Thermal Ablation for Multisite Metastatic Colon Cancer in an Elderly Patient.
   Anticancer Res. 2026;46:5789-5797.
   PubMed     Abstract available
   
   
   September 2026
7. KAMADA T, Takano Y, Goto K, Tsukihara S, et al
   High Cancer Inflammation Prognostic Index Identifies Patients With Stage II Colorectal Cancer With Outcomes Comparable to Stage III.
   Anticancer Res. 2026;46:5205-5215.
   PubMed     Abstract available
   
   
   
8. YAGYU T, Yamamoto M, Tsuda A, Ashida K, et al
   Lymphocyte Count Predicts Adjuvant Chemotherapy Completion After Severe Postoperative Complications in Colorectal Cancer.
   Anticancer Res. 2026;46:5055-5065.
   PubMed     Abstract available
   
   
   
9. ISHIKAWA I, Takagi K, Fuji T, Yasui K, et al
   Technical Considerations of the Jejunal Limb Route During Pancreaticoduodenectomy Following Total Colectomy for Familial Adenomatous Polyposis: A Case Report and Literature Review.
   Anticancer Res. 2026;46:5311-5317.
   PubMed     Abstract available
   
   
   
10. KIM JS, Im CM, Oh HH, Park SY, et al
    Malformin A1 Enhances 5-Fluorouracil-induced Apoptosis, Cell Cycle Arrest, and Anti-angiogenesis in Colorectal Cancer Cells.
    Anticancer Res. 2026;46:4959-4972.
    PubMed     Abstract available
    
    
    
11. IKUTA S, Aihara T, Nakajima T, Iwasaki T, et al
    Repeat Hepatectomy Versus Thermal Ablation for Intrahepatic Recurrence After Resection of Colorectal Liver Metastases: A Propensity-adjusted Analysis With Multiple Imputation.
    Anticancer Res. 2026;46:5281-5287.
    PubMed     Abstract available
    
    
    
12. YUSA T, Masuda T, Tomiguchi M, Nagayama Y, et al
    A Case of Concurrent Liver Metastases from Colorectal and Breast Cancer Diagnosed Using Percutaneous Tumor Biopsy.
    Anticancer Res. 2026;46:5339-5345.
    PubMed     Abstract available
    
    
    August 2026
13. SUZUKI H, Okuda H, Saito H, Tsuji T, et al
    CD44 Translocates in the Nucleus of Tumor Cells in a Colitis-associated Colorectal Cancer Mouse Model.
    Anticancer Res. 2026;46:4193-4202.
    PubMed     Abstract available
    
    
    
14. KITAGUCHI T, Abe S, Matsumoto T, Yoshida K, et al
    Pyra-Metho-Carnil Suppresses CD73-associated Macrophage Infiltration in KRAS-mutant Colorectal Cancer.
    Anticancer Res. 2026;46:4649-4663.
    PubMed     Abstract available
    
    
    
15. KAMADA T, Takano Y, Goto K, Tsukihara S, et al
    A Preoperative Symptom-tumor-nutrition Score Predicting Survival After Laparoscopic Resection for Colorectal Cancer.
    Anticancer Res. 2026;46:4499-4507.
    PubMed     Abstract available
    
    
    
16. KINUGASA T, Matsumoto T, Okada T, Sudo T, et al
    MUC5AC, CEACAM7, and DUOX2 Distinguish Colitis-associated Cancer from Sporadic Colorectal Cancer.
    Anticancer Res. 2026;46:4707-4717.
    PubMed     Abstract available
    
    
    
17. YOSHIDA N, Takamatsu M, Takaki K, Hisada K, et al
    Analysis for IL-22/ IL-22BP Axis and Cell Adhesion Molecules in Advanced Colorectal Cancer.
    Anticancer Res. 2026;46:4627-4637.
    PubMed     Abstract available
    
    
    
18. WANG S, Minagawa T, Toyoda Y, Sadanaga T, et al
    Leucine-rich KQLLL Motif Coordinates Secretion, Nuclear Localization, and Proliferation of Chitinase 3-like 1.
    Anticancer Res. 2026;46:4681-4687.
    PubMed     Abstract available
    
    
    July 2026
19. MA R, Shimura T, Huang Y, Yoshimura K, et al
    Anti-tumor Effects of Loureirin A Treatment in Colorectal Cancer Cells via Inhibition of AKT Phosphorylation.
    Anticancer Res. 2026;46:3627-3638.
    PubMed     Abstract available
    
    
    
20. DEMIRORS B, Godbole N, Brock LF, Bowers JC, et al
    Geographic Disparities in Socioeconomic Factors and Advanced-stage Presentation in Rectosigmoid Cancer: A National Cancer Database Analysis.
    Anticancer Res. 2026;46:3871-3878.
    PubMed     Abstract available
    
    
    
21. SHIBUTANI M, Seki Y, Kasashima H, Maeda K, et al
    Surgical Treatment and Postoperative Surveillance for Familial Adenomatous Polyposis.
    Anticancer Res. 2026;46:3583-3591.
    PubMed     Abstract available
    
    
    
22. KUO TC, Wang WC, Hsiao WP, Yen Y, et al
    Association Between Body Mass Index and Overall Survival in Patients With Colorectal Cancer in Taiwan.
    Anticancer Res. 2026;46:4139-4150.
    PubMed     Abstract available
    
    
    June 2026
23. FUNAKOSHI K, Sasaki K, Hata K, Nozawa H, et al
    Genomic Profiling of Cancerous Areas, Dysplasia, and Background Mucosa in Ulcerative Colitis-associated Colorectal Cancer.
    Anticancer Res. 2026;46:3281-3291.
    PubMed     Abstract available
    
    
    
24. MAEDA K, Koyama S, Kawada K, Hayashi T, et al
    Fosnetupitant Versus Fosaprepitant for Delayed Vomiting Upon Irinotecan-Oxaliplatin Combination Chemotherapy for Pancreatic/Colorectal Cancer.
    Anticancer Res. 2026;46:3191-3203.
    PubMed     Abstract available
    
    
    
25. RAFIQUE A, Koh YS
    Unveiling the Anti-tumor Actions and Therapeutic Potential of Calcitriol in Colorectal Cancer.
    Anticancer Res. 2026;46:2985-3004.
    PubMed     Abstract available
    
    
    
26. MURAI Y, Sugimoto K, Irie T, Fujisaki T, et al
    Circulating Tumor DNA Methylation Level Is a More Accurate Prognostic Biomarker in Colon Cancer.
    Anticancer Res. 2026;46:3267-3280.
    PubMed     Abstract available
    
    
    May 2026
27. SHIRAISHI T, Tominaga T, Nonaka T, Takamura Y, et al
    Prognostic Significance of the Lymph Node Ratio in Obstructive Colorectal Cancer: A Retrospective Multicenter Study.
    Anticancer Res. 2026;46:2703-2711.
    PubMed     Abstract available
    
    
    
28. ISHII K, Tauchi Y, Yano T
    Evaluation of Combined Treatment With Atorvastatin and SREBP2 Inhibitors Against Colorectal Cancer Cells Under Two-dimensional and Three-dimensional Culture Models.
    Anticancer Res. 2026;46:2403-2415.
    PubMed     Abstract available
    
    
    
29. SALIMIAGHDAM N, Yang X, Liang H
    The Ovarian Portal: An Unusual Pathway to Discovery, A Rare Initial Manifestation of Colon Cancer.
    Anticancer Res. 2026;46:2915-2923.
    PubMed     Abstract available
    
    
    
30. ADACHI Y, Matsuda T, Inubushi S, Yasuda K, et al
    Serum Extracellular Vesicles Double-positive for CD9 and CD147 or for CD9 and CD63 Decrease After Surgical Resection in Patients With Colorectal Cancer: Potential Biomarkers of Residual Tumor.
    Anticancer Res. 2026;46:2345-2352.
    PubMed     Abstract available
    
    
    
31. KYROS E, Mylonakis A, Kastanaki P, Velliou RI, et al
    Cytometry by Time-of-Flight for Profiling Therapeutic Response in Colorectal Cancer: Strengths, Limitations, and Translational Challenges.
    Anticancer Res. 2026;46:2297-2316.
    PubMed     Abstract available
    
    
    
32. KOBAYASHI Y, Takano Y, Fukushima A, Takishima T, et al
    Prognostic Impact of the Geriatric Nutritional Risk Index in Elderly Patients With Colorectal Cancer.
    Anticancer Res. 2026;46:2753-2762.
    PubMed     Abstract available
    
    
    
33. ISHII K, Yano T
    6-O-Carboxypropyl-alpha-Tocotrienol Enhances the Anticancer Effects of Bortezomib Without Suppressing NRF1 and NRF3 in Colorectal Cancer Cells.
    Anticancer Res. 2026;46:2375-2386.
    PubMed     Abstract available
    
    
    
34. KIM J, Han Q, Li S, Kang BM, et al
    Sulfasalazine an Inhibitor of System x(C) (-) (Cystine/glutamate Antiporter), Combined With Recombinant Methioninase, Inhibits Both Cancer and Normal Cells, Suggesting Lack of Cancer Selectivity of Cysteine Restriction.
    Anticancer Res. 2026;46:2353-2359.
    PubMed     Abstract available
    
    
    
35. KOMORI K, Kinoshita T, Ouchi A, Kishida T, et al
    Laparotomy After Total Pelvic Exenteration: Current Status and Techniques for Ileal Conduit Preservation.
    Anticancer Res. 2026;46:2735-2741.
    PubMed     Abstract available
    
    
    
36. ZHANG Z, Tu H, Han Z, Wang S, et al
    Profiling of Lysine Lactylation Reveals Its Proliferation-promoting Functions in Colorectal Cancer Cells.
    Anticancer Res. 2026;46:2565-2581.
    PubMed     Abstract available
    
    
    
37. THI TN, Nguyen VT, Thanh HD, Kwon SY, et al
    Inhibition of AP-1 Reduces CD46-mediated Invasion of Bladder and Colon Cancer Cells.
    Anticancer Res. 2026;46:2525-2539.
    PubMed     Abstract available
    
    
    
38. MATOBA D, Saito T, Noda T, Uemura M, et al
    PD-1(+)Tim-3(+)CD103(+) CD8(+) Tumor-infiltrating Lymphocytes Are Associated With Favorable Outcomes in Colorectal Cancer.
    Anticancer Res. 2026;46:2387-2401.
    PubMed     Abstract available
    
    
    April 2026
39. KONDOR AE, Vereczkei A, Varga P, Sindler LD, et al
    The Role of MRI in the Preoperative Staging of Rectal Cancer: Ten-year Experience from a Single Tertiary Center.
    Anticancer Res. 2026;46:2125-2132.
    PubMed     Abstract available
    
    
    
40. SAELIM P, Ei ZZ, Racha S, Yokoya M, et al
    Methoxy and Ketone Substitutions of Resveratrol Enhance Its Anticancer Activity by Increasing MEK and ERK Binding Affinity in Colorectal Cancer Cells.
    Anticancer Res. 2026;46:1957-1966.
    PubMed     Abstract available
    
    
    
41. KATAYAMA R, Aoki T, Tashiro Y, Hirai T, et al
    Relationship Between Histopathological Growth Patterns and Indocyanine Green Fluorescence in Colorectal Liver Metastases.
    Anticancer Res. 2026;46:2087-2093.
    PubMed     Abstract available
    
    
    March 2026
42. LOPES C, Macedo-Silva C, Farinha M, Costa J, et al
    Exploring SLC1A5 (ASCT2), SLC7A5, and SLC3A2 (LAT1) Genetic Variants in Colorectal Cancer: Implications for Prognosis and Personalized Care.
    Anticancer Res. 2026;46:1281-1292.
    PubMed     Abstract available
    
    
    
43. MAIMON O, Nisman B, Ben-David I, Kuznetz A, et al
    Autologous Tumor Vaccination in Melanoma and Colon Cancer Patients With Recurrent Liver Metastases: A Case Series.
    Anticancer Res. 2026;46:1569-1575.
    PubMed     Abstract available
    
    
    
44. GKEKAS I, Novotny J, Kaprio T, Fabian P, et al
    Risk of Non-colorectal Malignancies in Sporadic Versus Lynch Syndrome-associated dMMR Colorectal Cancer.
    Anticancer Res. 2026;46:1489-1496.
    PubMed     Abstract available
    
    
    
45. KAUR H, Bhall GIS, Lauder C, DA Silva N, et al
    Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Outcomes for Colorectal and Mesothelioma Peritoneal Metastases: A 12-year Study.
    Anticancer Res. 2026;46:1507-1515.
    PubMed     Abstract available
    
    
    
46. TAKCI RG, Sarac B, Hacisuleyman L, Sahinbas B, et al
    Synergistic Anticancer Effects of the PLK1 Inhibitor BI-2536 and beta-Glucan in Colon and Gastric Cancer Cells.
    Anticancer Res. 2026;46:1461-1474.
    PubMed     Abstract available
    
    
    February 2026
47. KIM J, Han Q, Li S, Kang BM, et al
    Lack of Cancer Specificity of Methionine Adenosyltransferase 2A (MAT2A) Inhibitor AG-270 in Combination With Recombinant Methioninase In Vitro.
    Anticancer Res. 2026;46:705-712.
    PubMed     Abstract available
    
    
    
48. TANDA H, Shibutani M, Seki Y, Nishiyama T, et al
    The Usefulness of the Modified Controlling Nutritional Status Score for Assessing Prognosis in Patients With Colorectal Cancer.
    Anticancer Res. 2026;46:1097-1105.
    PubMed     Abstract available
    
    
    
49. YAMANAKA R, Matsumoto N, Murase R, Kubota Y, et al
    Polymorphisms of FGFR Pathway-related Factors and Capecitabine-induced Hand-foot Syndrome in Japanese Patients With Colorectal Cancer.
    Anticancer Res. 2026;46:835-846.
    PubMed     Abstract available
    
    
    
50. OKADO S, Nakamura S, Sugihara M, Kinoshita F, et al
    Prognostic Factors for Pulmonary Metastasectomy for Colorectal Cancer: A Propensity Score Matching Analysis.
    Anticancer Res. 2026;46:1143-1152.
    PubMed     Abstract available
    
    
    
51. KUWATA D, Shimoda H, Miura T, Chiba T, et al
    Anatomical-specific Lymphatic Route Beyond Mesorectal Fascia: Analyses from Female Cadavers and Patients With Rectal Cancer.
    Anticancer Res. 2026;46:885-899.
    PubMed     Abstract available
    
    
    
52. INOUE A, Ota H, Matsuura Y, Munakata K, et al
    First-line FOLFOXIRI-based Chemotherapy for Unresectable Metastatic Colorectal Cancer: Real-world Outcomes, Safety, and Conversion Surgery.
    Anticancer Res. 2026;46:975-985.
    PubMed     Abstract available
    
    
    
53. SEKI Y, Shibutani M, Tanda H, Tsukida T, et al
    Impact of the Immunonutritional Status on the Feasibility of Subsequent Treatment After the Discontinuation of Trifluridine-Tipiracil Plus Bevacizumab Therapy in Patients With Metastatic Colorectal Cancer.
    Anticancer Res. 2026;46:1117-1122.
    PubMed     Abstract available
    
    
    
54. KIM HB, Lee HJ, Park SG
    Oncogenic Role and Clinical Significance of NPM1 in Colorectal Cancer via the AKT/mTOR Signaling Pathway.
    Anticancer Res. 2026;46:727-736.
    PubMed     Abstract available
    
    
    
55. KUO CY, Liao TL, Hsu FT, Chang CM, et al
    Lenvatinib Exhibits Potent Anti-tumor Activity and Favorable Safety Profile in a Colorectal Cancer Xenograft Model.
    Anticancer Res. 2026;46:797-810.
    PubMed     Abstract available
    
    
    January 2026
56. KOSUGE T, Mazaki J, Kasahara K, Osakabe H, et al
    Prediction of the Clinicopathological Prognosis of Colon Cancer After Radical Resection Using Artificial Intelligence "TabNet".
    Anticancer Res. 2026;46:467-474.
    PubMed     Abstract available
    
    
    
57. NARIHIRO S, Kitaguchi D, Ryu S, Fukuda M, et al
    Short-term Outcomes of Robotic-assisted Versus Laparoscopic Right Hemicolectomy for Right-sided Colon Cancer: A Retrospective Study.
    Anticancer Res. 2026;46:493-501.
    PubMed     Abstract available
    
    
    
58. KIM BH, Lee J, Lee D, Kim K, et al
    Immune Microenvironment Signatures Predict Response and Survival in Rectal Cancer Patients After Neoadjuvant Chemoradiation.
    Anticancer Res. 2026;46:123-134.
    PubMed     Abstract available
    
    
    
59. MATSUBARA D, Soga K, Fujita Y, Ochi F, et al
    Oncological Outcomes of Laparoscopic Surgery With Stent Bridge in Stage II-III Obstructive Colorectal Cancer.
    Anticancer Res. 2026;46:347-357.
    PubMed     Abstract available
    
    
    
60. KATAYAMA H, Noda K, Tominaga T, Hashimoto S, et al
    Effect of the Endoscopic Surgical Skill Qualification System for Colorectal Cancer Surgery With Multivisceral Resection on Long-term Outcomes: Japanese Multicenter Analysis.
    Anticancer Res. 2026;46:457-465.
    PubMed     Abstract available
    
    
    
61. NODA K, Tominaga T, Hashimoto S, Yamashita M, et al
    Effect of Pathological Response After Neoadjuvant Chemotherapy on Long-term Outcomes in Locally Advanced Colorectal Cancer: A Japanese Multicenter Study.
    Anticancer Res. 2026;46:327-336.
    PubMed     Abstract available
    
    
    
62. OHTAKI KI, Takeuchi R, Iwayama K, Chuma M, et al
    Evaluation of Regorafenib-induced Pancreatic Enzyme Elevation in Metastatic Colorectal Cancer Treatment.
    Anticancer Res. 2026;46:359-369.
    PubMed     Abstract available
    
    
    December 2025
63. MUECKE R, Fakhrian K, Gosenheimer R, Schmitz V, et al
    Neoadjuvant Radiochemotherapy for Locally Advanced Rectal Cancer: A Single-institutional Real-world Study.
    Anticancer Res. 2025;45:5513-5521.
    PubMed     Abstract available
    
    
    
64. KIM J, Han Q, Li S, Kang BM, et al
    The Combination of Recombinant Methioninase and Low-dose Chloroquine Selectively Eradicates Colon-Cancer Cells Without Apparent Toxicity on Co-cultured Normal Fibroblasts.
    Anticancer Res. 2025;45:5313-5320.
    PubMed     Abstract available
    
    
    
65. FURUKAWA K, Haruki K, Shirai Y, Onda S, et al
    Pulmonary Emphysema Assessed by the Goddard Score Predicts Outcomes After Hepatic Resection for Colorectal Liver Metastases.
    Anticancer Res. 2025;45:5765-5772.
    PubMed     Abstract available
    
    
    
66. YONEMITSU K, Kasashima H, Fukuoka T, Tanaka A, et al
    Successful Reconstruction of Recurrent Perineal Hernia After APR Using a Vertical Rectus Abdominis Myocutaneous Flap: A Salvage Option for a Refractory Case.
    Anticancer Res. 2025;45:5813-5817.
    PubMed     Abstract available
    
    
    November 2025
67. KOTAKE Y, Tanigawa Y, Ikenaga H, Kitagawa T, et al
    OIP5-AS1 Positively Regulates the Proliferation of Colorectal Cancer Cells by Repressing Apoptosis.
    Anticancer Res. 2025;45:4783-4790.
    PubMed     Abstract available
    
    
    
68. KIM MW, Kim D, Lee SE, Ahn J, et al
    JI-CJ002, a Natural Herbal Formula, Enhances the Antitumor Efficacy of FOLFOX in Colorectal Cancer by Suppressing the DDR Pathway.
    Anticancer Res. 2025;45:4987-5000.
    PubMed     Abstract available
    
    
    
69. MARUTA H, Noda K, Tominaga T, Hashimoto S, et al
    Efficacy and Safety of Robotic Surgery for Bulky Colorectal Tumors.
    Anticancer Res. 2025;45:5139-5146.
    PubMed     Abstract available
    
    
    
70. SHIMASAKI M, Kiyozumi Y, Ohmura R, Matsuishi K, et al
    Pathological Complete Response in Locally-advanced MSI-H/dMMR Sigmoid Colon Cancer Treated With Pembrolizumab and Abdominal Reconstruction.
    Anticancer Res. 2025;45:5239-5246.
    PubMed     Abstract available
    
    
    
71. TSAI YF, Wu MH, Lin TC, Yueh TC, et al
    Contribution of Xeroderma Pigmentosum Complementation Group C Genotypes to Colorectal Cancer in Taiwanese.
    Anticancer Res. 2025;45:4751-4763.
    PubMed     Abstract available
    
    
    
72. KITAGUCHI D, Enomoto T, Hoshiai S, Furuya K, et al
    Preoperative Risk Analysis for Postoperative Recurrence in Locally Advanced Rectal Cancer Following Chemoradiotherapy.
    Anticancer Res. 2025;45:5147-5157.
    PubMed     Abstract available
    
    
    
73. HOSOKAWA A, Yamada R, Otsuki Y, Tamura H, et al
    Remarkable and Durable Tumor Response to Pembrolizumab in Locally Advanced dMMR/MSI-H Rectal Cancer.
    Anticancer Res. 2025;45:5069-5076.
    PubMed     Abstract available
    
    
    October 2025
74. TAKAHASHI H, Kojima D, Miyasaka Y, Wada H, et al
    Neoadjuvant Chemotherapy for Initially Resectable Metachronous Colorectal Cancer Liver Metastases Is Associated With Early Postoperative Relapse.
    Anticancer Res. 2025;45:4547-4564.
    PubMed     Abstract available
    
    
    
75. JIMENEZ PB, Merly AA, Shekouhi R, Demirors B, et al
    Survival Impact and Sociodemographic Correlates of Colon Cancer Surgery Refusal.
    Anticancer Res. 2025;45:4305-4313.
    PubMed     Abstract available
    
    
    
76. KANG BM, Han Q, Li S, Kim JS, et al
    Recombinant Methioninase Selectively Eliminates Cancer Cells Co-cultured With Normal Fibroblasts Indicating the High-Precision Efficacy of Targeting Methionine Addiction of Cancer.
    Anticancer Res. 2025;45:4193-4200.
    PubMed     Abstract available
    
    
    
77. FUKATA K, Ogura A, Murata Y, Kobayashi R, et al
    The Impact of Adjuvant Chemotherapy in Patients With Locally Advanced Rectal Cancer After Neoadjuvant Chemotherapy: A Propensity Score Matching Cohort Study.
    Anticancer Res. 2025;45:4431-4439.
    PubMed     Abstract available
    
    
    
78. CIFTCI M, Ozgur E, Kulle CB, Gezer U, et al
    Exploring the Clinical Significance of Circulating H19 lncRNA and IGF-2 mRNA in Colorectal Carcinoma.
    Anticancer Res. 2025;45:4243-4251.
    PubMed     Abstract available
    
    
    
79. HARISI R, Jaray B, Zsirka A, Kulka J, et al
    Differential PCNA Expression Between Neoplastic and Adjacent Mucosa as a Prognostic Marker in Colorectal Adenoma-Carcinoma Progression.
    Anticancer Res. 2025;45:4415-4430.
    PubMed     Abstract available
    
    
    September 2025
80. WADA N, Nishida N, Takeda M, Sekido Y, et al
    Efficacy and Safety of S-1 and Oxaliplatin With Radiotherapy for Anorectal Cancer.
    Anticancer Res. 2025;45:3847-3857.
    PubMed     Abstract available
    
    
    
81. OTANI K, Kazama K, Aoyama T, Hashimoto I, et al
    Geriatric Nutritional Risk Index Predicts Prognosis in Older Patients With Colorectal Cancer: A Multicenter Study.
    Anticancer Res. 2025;45:4015-4025.
    PubMed     Abstract available
    
    
    
82. KOKAINE L, Daneberga Z, Satcs M, Zvina D, et al
    The Prognostic Role of microRNAs 142-5p, 182-3p, and 99a-3p in Locally Advanced Rectal Cancer Patients.
    Anticancer Res. 2025;45:3895-3912.
    PubMed     Abstract available
    
    
    
83. KIM J, Han Q, Li S, Kang BM, et al
    Combinations of Salmonella typhimurium A1-R, Recombinant Methioninase, and Chloroquine, Each Targeting Fundamental Cancer Hallmarks, Are Selectively Effective on Colon Cancer Cells Compared to Normal Fibroblasts.
    Anticancer Res. 2025;45:3661-3668.
    PubMed     Abstract available
    
    
    
84. NOZAWA H, Kasuga SO, Murono K, Sasaki K, et al
    Effects of Neoadjuvant Treatments on Mesorectal Computed Tomography Values and Tumor Regression in Rectal Cancer.
    Anticancer Res. 2025;45:3921-3930.
    PubMed     Abstract available
    
    
    
85. KIMURA N, Hiraki M, Furukawa S, Ikuno H, et al
    Oncological Outcomes of Varying Resection Margin Lengths in Colon Cancer Surgery: A Retrospective Analysis.
    Anticancer Res. 2025;45:4005-4013.
    PubMed     Abstract available
    
    
    August 2025
86. OGURA A, Murata Y, Sando M, Kobayashi R, et al
    Response-guided Strategy Based on Induction Chemotherapy Without Routine Use of Radiotherapy for Locally Advanced Rectal Cancer.
    Anticancer Res. 2025;45:3393-3398.
    PubMed     Abstract available
    
    
    
87. MUKOHYAMA J, Saito I, Mochizuki S, Ota Y, et al
    Endometrial Cancer Metastatic to the Sigmoid Colon and Pelvic Retroperitoneal Space: A Case Report.
    Anticancer Res. 2025;45:3567-3573.
    PubMed     Abstract available
    
    
    
88. LEE S, Koh JW, Lee JH, Park SJ, et al
    Silencing of Acyl-CoA Thioesterase 7 Inhibits Proliferation and Metastatic Potential in Colorectal Cancer Cells.
    Anticancer Res. 2025;45:3315-3325.
    PubMed     Abstract available
    
    
    July 2025
89. HUANG CW, Yang JS, Tsai YF, Kuo SC, et al
    Anti-cancer Effects of a Novel Curcumin Derivative, 4,4-Diallyl Curcumin Bis(2,2-Hydroxymethyl)Propanoate (35e), on Radio-resistant Colorectal Cancer Cells.
    Anticancer Res. 2025;45:2891-2904.
    PubMed     Abstract available
    
    
    
90. ASANO Y, Han Q, Li S, Mizuta K, et al
    The Combination of the Autophagy Inhibitor Chloroquine and Recombinant Methioninase Has Selective Synergistic Efficacy on Human Colon Cancer Cells But Not on Normal Human Fibroblasts.
    Anticancer Res. 2025;45:2825-2831.
    PubMed     Abstract available
    
    
    
91. KIM J, Han Q, Kang BM, Mizuta K, et al
    The Triple Combination of Recombinant Methioninase, Rapamycin, and Chloroquine Synergistically Eradicates HCT116 Colon Cancer Cells.
    Anticancer Res. 2025;45:2773-2779.
    PubMed     Abstract available
    
    
    
92. LEE J, Kim H, Moon J, Nualsanit T, et al
    Damnacanthal Suppresses TCF4 Expression in Colorectal Cancer Cells.
    Anticancer Res. 2025;45:2847-2858.
    PubMed     Abstract available
    
    
    
93. KANG BM, Han Q, Li S, Mizuta K, et al
    The Conditions of Non-rescuability of Methioninase-treated Cancer Cells by Methionine Replenishment: The Point of No Return.
    Anticancer Res. 2025;45:2817-2823.
    PubMed     Abstract available
    
    
    
94. NGUYEN MLT, Bui LA, Pham C, Nham PLT, et al
    Adiponectin Receptor Agonist Suppresses Human Colorectal Cancer.
    Anticancer Res. 2025;45:3059-3068.
    PubMed     Abstract available
    
    
    
95. VAN BUSSEL MTJ, Bravenboer N, Essen HV, Snaebjornsson P, et al
    Bone Toxicity Case Report Combining Encorafenib, Cetuximab and WNT974 in a Phase I Trial.
    Anticancer Res. 2025;45:3137-3147.
    PubMed     Abstract available
    
    
    
96. SUETSUGU F, Tadokoro T, Fujita K, Fujihara S, et al
    Antitumor Effects of Epigallocatechin-3-Gallate on Colorectal Cancer: An In Vitro and In Vivo Study.
    Anticancer Res. 2025;45:2937-2947.
    PubMed     Abstract available
    
    
    June 2025
97. MINAMI S, Miyoshi N, Fujino S, Yasui M, et al
    Role of the Circadian Clock Gene DEC1 in Chemosensitivity and Apoptosis in Colorectal Cancer.
    Anticancer Res. 2025;45:2309-2328.
    PubMed     Abstract available
    
    
    
98. YU X, Tsunedomi R, Hazama S, Nakagami Y, et al
    Immunogenicity of Neoantigens in Colorectal Cancer: Potential Influence of Tumor Mutation Burden, Stages, and Metastasis.
    Anticancer Res. 2025;45:2385-2399.
    PubMed     Abstract available
    
    
    
99. ANDO Y, Orito H, Mizuno T, Katsuno H, et al
    Effect of a Biweekly Dosing Schedule on Severe Neutropenia Induced by Trifluridine/Tipiracil in Colorectal Cancer.
    Anticancer Res. 2025;45:2587-2594.
    PubMed     Abstract available
    
    
    
100. ESKELINEN M, Selander T, Guimaraes DP, Kaarniranta K, et al
     Four Different Artificial Intelligence Models Versus Logistic Regression to Enhance the Diagnostic Accuracy of Fecal Immunochemical Test in the Detection of Colorectal Carcinoma in a Screening Setting.
     Anticancer Res. 2025;45:2477-2491.
     PubMed     Abstract available
     
     
     
101. KODAMA H, Yamaguchi T, Kameishi S, Kadono T, et al
     Tumor Budding Grade and T Stage as Recurrence Predictors of High-risk Stage II Colorectal Cancer.
     Anticancer Res. 2025;45:2619-2628.
     PubMed     Abstract available
     
     
     
102. KATAOKA A, Kawasaki T, Kaira K, Hirano Y, et al
     Pathological Investigation of Grasping-related Mesenteric Injury During Laparoscopic Colorectal Cancer Resection.
     Anticancer Res. 2025;45:2493-2499.
     PubMed     Abstract available
     
     
     
103. ASANO Y, Han Q, Li S, Mizuta K, et al
     Selective Synergy of Ivermectin Combined With Recombinant Methioninase Against Colon-Cancer Cells in Contrast to Normal Fibroblasts.
     Anticancer Res. 2025;45:2257-2263.
     PubMed     Abstract available
     
     
     
104. KOBAYASHI Y, Takano Y, Matsukida S, Takishima T, et al
     Prognostic Nutritional Index Is the Key Prognostic Factor in Elderly Patients With Colorectal Cancer.
     Anticancer Res. 2025;45:2595-2603.
     PubMed     Abstract available
     
     
     May 2025
105. HWANG HH, Yoo JS, Je JH, Lee HC, et al
     SH003 Inhibits Proliferation and Induces Apoptosis in Colon Cancer Through the RTK-STAT3 Pathway.
     Anticancer Res. 2025;45:1965-1980.
     PubMed     Abstract available
     
     
     
106. IZUTANI Y, Ogino T, Fujii M, Sekido Y, et al
     Appendectomy Mitigates Ulcerative Colitis Activity and Delays Colorectal Cancer Onset: A Retrospective Cohort Study.
     Anticancer Res. 2025;45:2205-2214.
     PubMed     Abstract available
     
     
     April 2025
107. OKEMOTO D, Yamaguchi T, Sugino K, Matsuo N, et al
     Chemotherapy Efficacy in Patients With Colorectal Cancer Experiencing Early Recurrence During or After Adjuvant Chemotherapy.
     Anticancer Res. 2025;45:1695-1705.
     PubMed     Abstract available
     
     
     
108. YUEH TC, Chen YJ, Mong MC, Ke TW, et al
     The Contribution of Interleukin-12A and Interleukin-12B Genotypes to Colorectal Cancer in Taiwan.
     Anticancer Res. 2025;45:1501-1512.
     PubMed     Abstract available
     
     
     
109. NII T, Yoshimi T, Tanito K, Hijii S, et al
     Inflammation-triggering Engineered Macrophages (MacTriggers) Are Promising Cell-based Therapeutic Avenues for Chemoresistant Solid Tumors.
     Anticancer Res. 2025;45:1395-1405.
     PubMed     Abstract available
     
     
     
110. SUGIMOTO K, Irie T, Momose H, Kochi S, et al
     Circulating Tumor DNA Methylation Is a Biomarker of Poor Recurrence-free Survival in Locally-Advanced Rectal Cancer.
     Anticancer Res. 2025;45:1559-1573.
     PubMed     Abstract available
     
     
     March 2025
111. TERAISHI F, Yoshida Y, Shoji R, Kanaya N, et al
     Short-term Safety of Robot-assisted Rectal Surgery in Patients Aged >/=75 Years: A Single-center Retrospective Study.
     Anticancer Res. 2025;45:1291-1299.
     PubMed     Abstract available
     
     
     
112. WEISS TS, Buechler C
     Proprotein Convertase Subtilisin/Kexin Type 9 Induction in Hypercholesterinemic Patients With Primary and Metastatic Liver Tumors.
     Anticancer Res. 2025;45:1171-1180.
     PubMed     Abstract available
     
     
     
113. SHOJI R, Teraishi F, Kondo Y, Yoshida Y, et al
     Tailoring Neoadjuvant Therapy for Rectal Cancer: A Single-center Study of Local Recurrence Patterns.
     Anticancer Res. 2025;45:1261-1271.
     PubMed     Abstract available
     
     
     
114. GOTO K, Ryu S, Imaizumi Y, Iwauchi S, et al
     Urethral Visualization Using Near-infrared Light Observation During Transanal/Perineal Total Mesorectal Excision.
     Anticancer Res. 2025;45:1241-1249.
     PubMed     Abstract available
     
     
     
115. SUGIYAMA M, Kasagi Y, Yokomizo R, Terashi M, et al
     Oncologic Relevance and Anal Preservation Potential of Transanal Total Mesorectal Excision for Rectal Cancer Invading Adjacent Organs.
     Anticancer Res. 2025;45:1233-1239.
     PubMed     Abstract available
     
     
     February 2025
116. DREVS J, Malhotra MS, Sahinbas H, Iliopoulos A, et al
     Adjusting Treatment Strategies Using Circulating Tumor Cells: Preliminary Results on Metastatic Colorectal Cancer.
     Anticancer Res. 2025;45:491-502.
     PubMed     Abstract available
     
     
     
117. YANG IJ, Kim DH, Lee KH, Kim JY, et al
     Safety and Survival Benefit of Adjuvant Chemotherapy for Elderly Patients With Stage II/III Colon Cancer.
     Anticancer Res. 2025;45:797-809.
     PubMed     Abstract available
     
     
     
118. TAKISHIMA T, Kobayashi Y, Matsukida S, Kai W, et al
     Negative Impact of Low Serum Cholinesterase on Short- and Long-term Outcomes in Elderly Patients Undergoing Scheduled Surgery for Colorectal Cancer.
     Anticancer Res. 2025;45:743-750.
     PubMed     Abstract available
     
     
     January 2025
119. KAWAMURA H, Imaizumi T, Miyakawa T, Nakao E, et al
     Development of a Prognostic Model for Stage IV Colorectal Cancer Using Metastatic Patterns.
     Anticancer Res. 2025;45:341-350.
     PubMed     Abstract available
     
     
     
120. ZHANG Y, Li X, Li S, Yang Z, et al
     Alternating Oxaliplatin and Irinotecan Chemotherapy Combined With Capecitabine and Bevacizumab for Microsatellite-stable Stage IV Metastatic Colon Cancer With a BRAF V600E Mutation: Two Case Reports Indicating Survival Improvement over Standard Therap
     Anticancer Res. 2025;45:399-404.
     PubMed     Abstract available
     
     
     
121. KASUGA SO, Nozawa H, Ishihara S
     Changes in Mesorectal CT Values and Therapeutic Effect of Preoperative Chemoradiotherapy in Rectal Cancer.
     Anticancer Res. 2025;45:359-367.
     PubMed     Abstract available
     
     
     
122. ESKELINEN M, Selander T, Guimaraes DP, Kaarniranta K, et al
     Artificial Intelligence Models Could Enhance the Diagnostic Accuracy (DA) of Fecal Immunochemical Test (FIT) in the Detection of Colorectal Adenoma in a Screening Setting.
     Anticancer Res. 2025;45:267-275.
     PubMed     Abstract available
     
     
     
123. TSAI YY, Ke TW, Huang CH, Chen TW, et al
     Prognostic Relevance of Immunosuppressive CD155/TIGIT Signaling in Locally Advanced Rectal Cancer Patients With Neoadjuvant Chemoradiotherapy.
     Anticancer Res. 2025;45:323-333.
     PubMed     Abstract available
     
     
     December 2024
124. KIM HB, Choi WY, Kim SH, Lee HJ, et al
     GNAO1: A Novel Tumor Suppressor Gene in Colorectal Cancer Pathogenesis.
     Anticancer Res. 2024;44:5425-5433.
     PubMed     Abstract available
     
     
     
125. SHIBUTANI M, Kashiwagi S, Tanda H, Seki Y, et al
     Prognostic Significance of Innovative Inflammation-nutrition Biomarker Score in Patients With Colorectal Cancer.
     Anticancer Res. 2024;44:5559-5567.
     PubMed     Abstract available
     
     
     
126. SHIN H, Kim Y, Lee Y, Kim J, et al
     Chlorhexidine Dihydrochloride Shows Anti-tumor Effects in Desmoid Tumors and Colorectal Cancer.
     Anticancer Res. 2024;44:5435-5443.
     PubMed     Abstract available
     
     
     
127. LEE Y, Kim Y, Shin H, Ryu YC, et al
     Anti-tumor Effects of Idarubicin Hydrochloride in Desmoid Tumors.
     Anticancer Res. 2024;44:5313-5322.
     PubMed     Abstract available
     
     
     November 2024
128. ZADOROZNYJ A, Karam E, Michot N, Thiery J, et al
     Clinical and Oncological Impact of a Protective Ileostomy in Rectal Cancer Patients Undergoing Adjuvant Chemotherapy.
     Anticancer Res. 2024;44:4995-5005.
     PubMed     Abstract available
     
     
     
129. NGUYEN MLT, Pham C, Nguyen TS, Nham PLT, et al
     Single-agent Adavosertib Shows Anticancer Effects Against Colorectal Cancer Cells.
     Anticancer Res. 2024;44:4941-4949.
     PubMed     Abstract available
     
     
     
130. YASUI C, Kono Y, Ishiguro R, Yagyu T, et al
     New Treatment Modalities for Colorectal Cancer Through Simultaneous Suppression of FSP1 and GPX4.
     Anticancer Res. 2024;44:4905-4914.
     PubMed     Abstract available
     
     
     
131. SUNG YN, Kim Y, Datuin AT, Jang I, et al
     Routine Elastic Staining Helps Detection of Vascular Invasion in Colorectal Cancer: A Comprehensive Analysis of T3 or Higher Tumors Without Lymph Node Metastasis.
     Anticancer Res. 2024;44:5059-5065.
     PubMed     Abstract available
     
     
     October 2024
132. UNRUG-BIELAWSKA K, Earnshaw D, Cybulska-Lubak M, Kaniuga E, et al
     Therapeutic Responses to Two New SN-38 Derivatives in Colorectal Cancer Patient-Derived Xenografts and Respective 3D In Vitro Cultures.
     Anticancer Res. 2024;44:4219-4224.
     PubMed     Abstract available
     
     
     
133. RUBIO CA, Vieth M, Lang-Schwarz C
     Nondysplastic Colon Crypts Intercalated in Tubular Adenomas Support Field Cancerization.
     Anticancer Res. 2024;44:4371-4377.
     PubMed     Abstract available
     
     
     
134. HOSIK J, Hosikova B, Kolarova H, Bajgar R, et al
     5,10,15,20-Tetrakis(4-sulfonatophenyl)porphyrin Zinc and Chloro-aluminum Phthalocyanine Disulfonate in Photodynamic Therapy of Colorectal Adenocarcinoma In Vitro.
     Anticancer Res. 2024;44:4339-4346.
     PubMed     Abstract available
     
     
     
135. VIRGILIO E, Salvemini C, Treglia MG, Thai E, et al
     Hotspots of Anal Cancer Screening in a High-risk Population: A Clinical Study on Free Provision, Best Method, Self-sampling, and Independent Risk Factors.
     Anticancer Res. 2024;44:4465-4481.
     PubMed     Abstract available
     
     
     September 2024
136. HOSOKAWA A, Tamura H, Ichihara A, Imamura N, et al
     Pathological Complete Response to Liver Metastasis With Pembrolizumab in a Previously Treated Patient With Microsatellite Instability-high Colorectal Cancer.
     Anticancer Res. 2024;44:4119-4125.
     PubMed     Abstract available
     
     
     
137. SHIRAISHI T, Yamaguchi A, Shibasaki Y, Osone K, et al
     Risk Factors of Poor Outcomes After Colorectal Cancer Surgery for Patients With Severe Comorbidities.
     Anticancer Res. 2024;44:4073-4083.
     PubMed     Abstract available
     
     
     
138. COZZANI F, Ricchiuto M, Virgilio E, Viani L, et al
     The Controlling Nutritional Status (CONUT) Score Predicts Post-operatory Risks and Prognosis in Patients With Surgically Treated Colon Cancer: A Retrospective Study.
     Anticancer Res. 2024;44:3955-3964.
     PubMed     Abstract available
     
     
     
139. JINNO T, Yamaguchi J, Ogura A, Kokuryo T, et al
     Loss of Trefoil Factor 1 Accelerates the Immune Response to Colorectal Cancer.
     Anticancer Res. 2024;44:3757-3769.
     PubMed     Abstract available
     
     
     
140. FUKUSHIMA G, Sato E, Udo R, Tago T, et al
     Stromal CD4 (+) T Cell Subsets Mediate Antitumor Cytotoxic Immune Responses in Human Colorectal Carcinoma.
     Anticancer Res. 2024;44:3899-3906.
     PubMed     Abstract available
     
     
     
141. KAYANO H, Mamuro N, Kamei Y, Ogimi T, et al
     Risk Factors Associated With Perioperative Skeletal Muscle Loss in Patients With Colorectal Cancer.
     Anticancer Res. 2024;44:4019-4029.
     PubMed     Abstract available
     
     
     
142. TAKEDA K, Kikuchi Y, Sawada YU, Kumamoto T, et al
     Simultaneously Detected Liver and Lung Metastases from Colorectal Carcinoma: A Potential Treatment Strategy.
     Anticancer Res. 2024;44:3945-3954.
     PubMed     Abstract available
     
     
     August 2024
143. KAMADA T, Furukawa K, Takahashi J, Aida T, et al
     Preoperative Vertebral Fracture: A Prognostic Factor in Stage I-III Colorectal Cancer.
     Anticancer Res. 2024;44:3533-3541.
     PubMed     Abstract available
     
     
     
144. YOKOTA Y, Nozawa H, Sonoda H, Yokoyama Y, et al
     Indoleamine 2,3-Dioxygenase Inhibitor Suppresses Colon Cancer Cell Migration, Invasion, and Epithelial-Mesenchymal Transition.
     Anticancer Res. 2024;44:3337-3342.
     PubMed     Abstract available
     
     
     
145. TSUJIO G, Fukuoka T, Sugimoto A, Yonemitsu K, et al
     The Efficacy of Chemical Bowel Preparation Against Incisional Surgical Site Infection in Colorectal Cancer Surgery: A Propensity Score Matching Study.
     Anticancer Res. 2024;44:3473-3480.
     PubMed     Abstract available
     
     
     
146. FUKUDA J, Sudo T, Kikuchi M, Kawahara A, et al
     Identification of DNA Repair-related Genes as Biomarkers Reflecting MSI, TMB, and TIL in Colorectal Cancer.
     Anticancer Res. 2024;44:3567-3575.
     PubMed     Abstract available
     
     
     
147. TAKAHASHI H, Kojima D, Wada H, Hanaoka K, et al
     A Bridge to Curative Surgery for Obstructive Colorectal Cancer: Self-expandable Metallic Stent Versus Decompression Tube.
     Anticancer Res. 2024;44:3427-3441.
     PubMed     Abstract available
     
     
     
148. MUKOHYAMA J, Koizumi M, Yamashita K, Yoshimi A, et al
     Knockdown of CDX2 Induces microRNA-221 Up-regulation in Human Colon Cancer Cells.
     Anticancer Res. 2024;44:3553-3556.
     PubMed     Abstract available
     
     
     July 2024
149. KOMORI K, Yoshida M, Tsukushi S, Kinoshita T, et al
     Combined Pubic Arch and Ischial Bone Resection for Metachronous and Frequent Local Recurrences of Rectal Cancer.
     Anticancer Res. 2024;44:3205-3211.
     PubMed     Abstract available
     
     
     
150. LEE SH, Kim SA, Park SJ, Lee MY, et al
     NUAK2 Inhibitors, KHKI-01128 and KHKI-01215, Exhibit Potent Anticancer Activity Against SW480 Colorectal Cancer Cells.
     Anticancer Res. 2024;44:2909-2919.
     PubMed     Abstract available
     
     
     
151. SHIOI I, Ogawa H, Naito R, Endo M, et al
     Risks and Outcomes of Early Dose Reduction in Adjuvant CAPOX Therapy for Colorectal Cancer.
     Anticancer Res. 2024;44:3013-3023.
     PubMed     Abstract available
     
     
     
152. TSUMURAYA H, Mimura K, Nakajima S, Hanayama H, et al
     Tumor Infiltrating Effector Regulatory T Cells Express VEGF Receptor 2 in Patients With Colorectal Cancer.
     Anticancer Res. 2024;44:2933-2941.
     PubMed     Abstract available
     
     
     
153. KARLIKOVA M, Curillova M, Pecen L, Karnos V Jr, et al
     Evaluation of Serum Cytokeratines, Thymidine Kinase, and Growth Factors as Cancer Biomarkers in Colorectal Cancer.
     Anticancer Res. 2024;44:3105-3113.
     PubMed     Abstract available
     
     
     June 2024
154. MOON SU, Lee JH, Shah M, Yoon S, et al
     RRM2 Is a CTNNB1 Transport Regulator Promoting Colon Cancer Progression.
     Anticancer Res. 2024;44:2471-2485.
     PubMed     Abstract available
     
     
     
155. TOREN W, Sasor A, Ansari D, Andersson R, et al
     ARHGAP4 as a Prognostic Biomarker for Colon Liver Metastases After Surgical Resection.
     Anticancer Res. 2024;44:2597-2604.
     PubMed     Abstract available
     
     
     
156. MATSUDA A, Yamada T, Takahashi G, Matsumoto S, et al
     Significance of Adjuvant Chemotherapy for Obstructive Colorectal Cancer After Stent Placement: A Multicenter Retrospective Study.
     Anticancer Res. 2024;44:2737-2745.
     PubMed     Abstract available
     
     
     
157. LIM SC, Lee TB, Han SI
     Caffeic Acid Enhances Anticancer Drug-induced Apoptosis in Acid-adapted HCT116 Colon Cancer Cells.
     Anticancer Res. 2024;44:2587-2595.
     PubMed     Abstract available
     
     
     May 2024
158. WAGNER D, Karitnig R, Wienerroither V, Hau HM, et al
     Sarcopenic Obesity Promotes Recurrence in Patients Undergoing Resection for Colorectal Liver Metastases (CRLM).
     Anticancer Res. 2024;44:2177-2183.
     PubMed     Abstract available
     
     
     April 2024
159. WU CC, Su CC, Chen YH, Hsu CW, et al
     Comparative Effectiveness of Adjuvant Therapy on Survival in Patients With Metastatic Colorectal Cancer.
     Anticancer Res. 2024;44:1619-1628.
     PubMed     Abstract available
     
     
     
160. TANAKA H, Hayashi H, Tomita H, Tokumaru Y, et al
     Association of Preoperative and Postoperative Plasma Syndecan-1 and Colorectal Cancer Outcome.
     Anticancer Res. 2024;44:1611-1618.
     PubMed     Abstract available
     
     
     
161. SHIRAISHI T, Tominaga T, Ono R, Noda K, et al
     Short- and Long-term Outcomes After Colonic Stent Insertion as a Bridge to Surgery in Elderly Colorectal Cancer Patients.
     Anticancer Res. 2024;44:1637-1643.
     PubMed     Abstract available
     
     
     
162. SYRJANEN K, Eskelinen M, Meklin J, Hendolin P, et al
     Colorectal Cancer Screening by Fecal Immunochemical Tests (FIT): Considerations on Sampling and Markers (Hb and Hb/Hp Complex) of Fecal Occult Blood (FOB).
     Anticancer Res. 2024;44:1513-1523.
     PubMed     Abstract available
     
     
     
163. BEPPU T, Yamamura K, Masuda T, Miyamoto H, et al
     High-risk Patients With Colorectal Liver Metastases Assessed by the Beppu Score Can Have Excellent Survival Through Multidisciplinary Treatment Including Local Ablation.
     Anticancer Res. 2024;44:1533-1539.
     PubMed     Abstract available
     
     
     
164. SATOYOSHI T, Hirohashi Y, Okuya K, Miyo M, et al
     CD8-positive T Cell Infiltration With Human Leukocyte Antigen Class 1 Expression Predicts Patients With Stage IV Colorectal Cancer Survival.
     Anticancer Res. 2024;44:1603-1610.
     PubMed     Abstract available
     
     
     
165. AOYAMA T, Yukawa N, Saito A
     Clinical Impact of Nutrition and Inflammation Assessment Tools in Colorectal Cancer Treatment.
     Anticancer Res. 2024;44:1335-1351.
     PubMed     Abstract available
     
     
     March 2024
166. ZHENG W, Chen K, Lv Y, Lao W, et al
     Pyrvinium Pamoate Induces Cell Apoptosis and Autophagy in Colorectal Cancer.
     Anticancer Res. 2024;44:1193-1199.
     PubMed     Abstract available
     
     
     
167. EBATA Y, Nakanishi R, Tanaka Y, Kawazoe T, et al
     Neoadjuvant Chemotherapy in Patients With T4b or Obstructive Colon Cancer: A Single Center Retrospective Cohort Study.
     Anticancer Res. 2024;44:1281-1287.
     PubMed     Abstract available
     
     
     
168. HARA S, Sakai D, Ikemura K, Shintani T, et al
     Comparative Efficacy and Safety of Standard and Biweekly Trifluridine/Tipiracil Regimen in Patients With Colorectal Cancer.
     Anticancer Res. 2024;44:1219-1226.
     PubMed     Abstract available
     
     
     
169. SILVA EF, Fernandes BN, Marinello P, Deminice R, et al
     Pre and Post-high-intensity Interval Training Delays Colon Tumor Onset in a Syngeneic Mouse Model.
     Anticancer Res. 2024;44:1209-1217.
     PubMed     Abstract available
     
     
     
170. HEGEDUS D, Szemeredi N, Gabor M, Sas J, et al
     Cyclic Amines Coupled to Indole Derivatives With Improved Efflux Pump Inhibiting Activity in Bacteria and Cancer Cells.
     Anticancer Res. 2024;44:1149-1160.
     PubMed     Abstract available
     
     
     
171. ARDJMAND D, Kubota Y, Sato M, Han Q, et al
     Selective Synergy of Rapamycin Combined With Methioninase on Cancer Cells Compared to Normal Cells.
     Anticancer Res. 2024;44:929-933.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum